What is the official ID of this bill?
The official print number for this legislation is HR 3282.
Increased Transparency in Medicare Advantage and Drug Programs
This bill aims to increase transparency in Medicare Advantage (Part C) and prescription drug (Part D) programs. It requires insurance companies and drug managers to disclose detailed data on ownership, payments, and costs, helping citizens better understand how these programs operate and where their money goes.
Key points
Medicare Advantage organizations will need to disclose data on services, diagnoses, and risk scores, especially if they have ownership ties with providers.
Pharmacy benefit managers (PBMs) will be required to disclose details on drug prices, rebates, and fees, which should help assess drug costs.
All collected information will be publicly available, but without revealing sensitive data, to promote fair competition and informed citizen choices.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.